Alarcon, N., Jaramillo, M., Mansour, H., & Sun, B. (2022). Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms. 14(7). https://doi.org/10.3390/pharmaceutics14071448

O’Malley, P., Jackson, J., Becher, D., Hanson, J., Lee, J., & Grace, K. (2022). Tool to improve patient-provider interactions in adult primary care: Randomized controlled pilot study. 68(2). https://doi.org/10.46747/cfp.6802e49

Slack, M., & Cooley, J. (2022). Using retrospective pretests to obtain subjective patient data: A case example. 79(8). https://doi.org/10.1093/ajhp/zxab452

Principe, D., Xiong, R., Li, X., Pham, T., Kamath, S., Dubrovskyi, O., Ratia, K., Huang, P.-L., Zhao, J., Shen, Z., Thummuri, D., Daohong, Z., Underwood, P., Trevino, J., Munshi, H., Thatcher, G., & Rana, A. (2022). XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer. 119(4). https://doi.org/10.1073/pnas.2116764119

Song, D., Kuang, L., Yang, S., Wang, L., Li, X., Li, X., Zhu, Z., Shi, C., Zhu, Z., & Gong, W. (2022). Yin and yang regulation of stress granules by Caprin-1. 119(44). https://doi.org/10.1073/pnas.2207975119

Faulkner, K., Macdonald, K., Abraham, I., Alhossan, A., & Lee, J. (2021). ’Real-world’ effectiveness of omalizumab in adults with severe allergic asthma: a meta-analysis. 17(1). https://doi.org/10.1080/1744666X.2020.1856658

Dhatt, H., Marupuru, S., & Warholak, T. (2021). A motivational factors assessment instrument for medication management center employees providing medication therapy management services: A Rasch analysis. 61(1). https://doi.org/10.1016/j.japh.2020.08.040

Cornelison, B., Al-Mohaish, S., Sun, B., & Edwards, C. (2021). Accuracy of Google Translate in translating the directions and counseling points for top-selling drugs from English to Arabic, Chinese, and Spanish. 78(22). https://doi.org/10.1093/ajhp/zxab224

Muralidharan, P., Hayes, D., Fineman, J., Black, S., & Mansour, H. (2021). Advanced Microparticulate/Nanoparticulate Respirable Dry Powders of a Selective RhoA/Rho Kinase (Rock) Inhibitor for Targeted Pulmonary Inhalation Aerosol Delivery. 13(12). https://doi.org/10.3390/pharmaceutics13122188

Acosta, M., Muralidharan, P., Grijalva, C., Abrahamson, M., Hayes, D., Fineman, J., Black, S., & Mansour, H. (2021). Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, 2D/3D human lung cell cultures, and efficacy. 15. https://doi.org/10.1177/1753466621998245

Josyula, A., Omiadze, R., Parikh, K., Kanvinde, P., Appell, M., Patel, P., Saeed, H., Sutar, Y., Anders, N., He, P., McDonnell, P., Hanes, J., Date, A., & Ensign, L. (2021). An ion-paired moxifloxacin nanosuspension eye drop provides improved prevention and treatment of ocular infection. 6(3). https://doi.org/10.1002/btm2.10238

Collins, K., Younis, U., Tanyaratsrisakul, S., Polt, R., Hay, M., Mansour, H., & Ledford, J. (2021). Angiotensin-(1-7) Peptide Hormone Reduces Inflammation and Pathogen Burden during Infection in Mice. 13(10). https://doi.org/10.3390/pharmaceutics13101614

Eedara, B., Encinas-Basurto, D., Alabsi, W., Polt, R., & Mansour, H. (2021). Applications of Surface Analytical Techniques in Characterization of Dry Powder Formulations.

Bingham, J., Stanislaw, J., Warholak, T., Scovis, N., Axon, D., Turgeon, J., & Marupuru, S. (2021). Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth.

Bingham, J., Stanislaw, J., Warholak, T., Scovis, N., Axon, D., Turgeon, J., & Marupuru, S. (2021). Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth. 18(12). https://doi.org/10.3390/ijerph18126560

Lee, J., McCutcheon, L., Fazel, M., Cooley, J., & Slack, M. (2021). Assessment of Interprofessional Collaborative Practices and Outcomes in Adults With Diabetes and Hypertension in Primary Care: A Systematic Review and Meta-analysis. 4(2). https://doi.org/10.1001/jamanetworkopen.2020.36725

Almutairi, A., Slack, M., Erstad, B., McBride, A., & Abraham, I. (2021). Association of immune-checkpoint inhibitors and the risk of immune-related colitis among elderly patients with advanced melanoma: real-world evidence from the SEER-Medicare database. 12. https://doi.org/10.1177/2042098621991279

Marupuru, S., & Axon, D. (2021). Association of Multimorbidity on Healthcare Expenditures Among Older United States Adults With Pain. 33(9). https://doi.org/10.1177/08982643211011841

Axon, D., & Emami, N. (2021). Association of Self-Reported Frequent Exercise Among a Nationally Representative Sample of Older People in the United States With Self-Reported Pain. 29(5). https://doi.org/10.1123/japa.2020-0268

Axon, D., & Le, D. (2021). Association of Self-Reported Functional Limitations among a National Community-Based Sample of Older United States Adults with Pain: A Cross-Sectional Study.

Axon, D., & Arku, D. (2021). Associations of multiple (≥5) chronic conditions among a nationally representative sample of older United States adults with self-reported pain. 21(4). https://doi.org/10.1515/sjpain-2021-0094

Sana, S., Reddy, S., Reddy, S., Tokala, R., Kumar, R., Bhargava, S., & Shankaraiah, N. (2021). Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies. 110. https://doi.org/10.1016/j.bioorg.2021.104765

AlRawashdh, N., Persky, D., McBride, A., Sweasy, J., Erstad, B., & Abraham, I. (2021). Comparative Efficacy of First-Line Treatments of Chronic Lymphocytic Leukemia: Network Meta-Analyses of Survival Curves. 21(11). https://doi.org/10.1016/j.clml.2021.06.010

Acosta, M., Muralidhran, P., Abrahamson, M., Grijalva, C., Carver, M., Tang, H., Klinger, C., Fineman, J., Black, S., & Mansour, H. (2021). Comparison of L-Carnitine and L-Carnitine HCL Salt for Targeted Lung Treatment of Pulmonary Hypertension (PH) as Inhalation Aerosols: Design, Comprehensive Characterization, In Vitro 2D/3D Cell Cultures, and In Vivo MCT-Rat Model of PH. https://doi.org/10.1016/j.pupt.2021.101998

Algotar, A., Hsu, C., Chow, H.-H., Dougherty, S., Babiker, H., Marrero, D., Abraham, I., Kumar, R., Ligibel, J., Courneya, K., Smith, T., Jones, B., Lopez, J., Niemiro, G., Ramakumar, S., Hoy, R., Mack, C., & Thomson, C. (2021). Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP) is associated with improvement in weight and components of metabolic syndrome in men exposed to androgen deprivation therapy for prostate cancer. 24(3). https://doi.org/10.1038/s41391-021-00346-z

Le, D., Paulk, I., Axon, D., & Bingham, J. (2021). Comprehensive Medication Review Completion in Medically Underserved Areas and Populations. 32(3). https://doi.org/10.1353/hpu.2021.0133

McBride, A., Macdonald, K., Fuentes-Alburo, A., & Abraham, I. (2021). Conversion from pegfilgrastim with on-body injector to pegfilgrastim-jmdb: cost-efficiency analysis and budget-neutral expanded access to prophylaxis and treatment. 24(1). https://doi.org/10.1080/13696998.2021.1916863

Macdonald, K., AlRawashdh, N., McBride, A., & Abraham, I. (2021). Conversion to biosimilar pegfilgrastim-cbqv enables budget-neutral access to FOLFIRINOX treatment for metastatic pancreatic cancer. 17(33). https://doi.org/10.2217/fon-2021-0718

McBride, A., Macdonald, K., & Abraham, I. (2021). Conversion to supportive care with biosimilar pegfilgrastim-cbqv enables budget-neutral expanded access to R-CHOP treatment in non-Hodgkin lymphoma. 106. https://doi.org/10.1016/j.leukres.2021.106591

Akinbami, L., Petersen, L., Sami, S., Vuong, N., Lukacs, S., Mackey, L., Atas, J., & LaFleur, B. (2021). Coronavirus Disease 2019 Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Positivity in a Large Survey of First Responders and Healthcare Personnel, May-July 2020. 73(3). https://doi.org/10.1093/cid/ciab080